Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy.
Andres Portocarrero-BonifazSalman SyedMaxwell KasselGrant W McKenzieVishwa M ShahBryce M ForryJeremy T GaskinsKeith T SowardsThulasi Babitha AvulaAdrianna MastersScott R SilvaPublished in: Brachytherapy (2024)
Syed-Neblett and T&O applicators are suitable for HDR brachytherapy for cervical cancer in distinct patient populations. Acute toxicities are more prevalent with T&O applicators, while patients treated with Syed-Neblett applicators are more likely to develop late toxicities.
Keyphrases
- high dose
- radiation therapy
- stem cell transplantation
- low dose
- papillary thyroid
- liver failure
- oxidative stress
- respiratory failure
- squamous cell
- locally advanced
- drug induced
- squamous cell carcinoma
- lymph node metastasis
- aortic dissection
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- rectal cancer
- monte carlo